Journal of Pediatric Surgery
Volume 44, Issue 11 , Pages 2071-2077 , November 2009

Effects of the administration of pentoxifylline and prednisolone on the evolution of portal fibrogenesis secondary to biliary obstruction—an experimental study in growing animals

Received 24 February 2009 ,Revised 10 May 2009 ,Accepted 11 May 2009.

References 

  1. Rojkind M. The liver as a bioecological system. In:  Arias IM,  Jakoby WB,  Popper H,  Schachter D,  Shafritz DA editor. The liver: biology and pathobiology. 2nd ed.. New York: Raven Press; 1988;p. 1269–1285
  2. Sokol RJ, Mack C. Etiopathogenesis of biliary atresia. Semin Liver Dis. 2001;21:517–524
  3. Carceller A, Blanchard H, Alvarez F, et al. Past and future of biliary atresia. J Pediatr Surg. 2000;5:717–720
  4. Karrer FM, Lilly JR. Corticosteroid therapy in biliary atresia. J Pediatr Surg. 1985;20:693–695
  5. Muraji T, Higashimoto Y. The improved outlook for biliary atresia with corticosteroid therapy. J Pediatr Surg. 1997;32:1103–1107
  6. Kobayashi H, Yamataka A, Koga H, et al. Optimum prednisolone usage in patients with biliary atresia postportoenterostomy. J Pediatr Surg. 2005;40:327–330
  7. Escobar MA, Jay CL, Brooks RM, et al. Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg. 2006;41:99–103
  8. Stringer MD, Davison SM, Rajwal SR, et al. Kasai portoenterostomy: 12-year experience with a novel adjuvant therapy regimen. J Pediatr Surg. 2007;42:1324–1328
  9. Albanis E, Friedman SL. Antifibrotic agents for liver disease. Am J Transplant. 2006;6:12–19
  10. Li X, Meng Y, Wu P, et al. Angiotensin II and aldosterone stimulating NF-κβ and AP-1 activation in hepatic fibrosis of rat. Regul Pept. 2007;138:15–25
  11. Oberti F, Pilette C, Rifflet H, et al. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation. J Hepatol. 1997;26:1363–1371
  12. Hsu YC, Chiu YT, Cheng CC, et al. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis. Hepatology. 2007;22:99–111
  13. Peterson TC, Neumeister M. Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism. Immunopharmacology. 1996;31:183–193
  14. Ward A, Clissold SP. Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy. Drugs. 1987;34:50–97
  15. Raetsch C, Jia JD, Boigk G, et al. Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis. Gut. 2002;50:241–247
  16. Schandené L, Vandenbussche P, Crusiaux A, et al. Differential effects of pentoxifylline on the production of tumor necrosis factor-alpha (TNFα) and interleukin-6 (IL-6) by monocytes and T cells. Immunology. 1992;76:30–34
  17. Tarçin O, Avsar K, Demirtürk L, et al. In vivo inefficiency of pentoxifylline and interferon-alpha on hepatic fibrosis in biliary-obstructed rats: assessment by tissue collagen content and prolidase activity. J Gastroenterol Hepatol. 2003;18:437–444
  18. Cameron GR, Oakley CL. Ligation of the common bile duct. J Pathol Bact. 1932;35:769–798
  19. Medeiros MVMJ, Freitas LAR, Andrade ZA. Differences in hepatic pathology resulting from bile duct obstruction in young and old rats. Braz J Med Biol Res. 1988;21:75–83
  20. Omori M, Evarts RP, Omori N, et al. Expression of α-fetoprotein and stem cell factor/c-kit system in bile duct ligated young rats. Hepatology. 1997;25:1115–1122
  21. Gibelli NE, Tannuri U, de Mello ES, et al. Bile duct ligation in neonatal rats: Is it a valid experimental model for biliary atresia studies. Pediatr Transplant. 2009;13:81–87
  22. Kisseleva T, Brenner DA. Role of hepatic cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol. 2007;22:S73–S78
  23. Demirbilek S, Tas E, Gurunluoglu K, Akin M, et al. Fluvastatin reduced liver injury in a rat model of extrahepatic cholestasis. Pediatr Surg Int. 2007;23:155–162
  24. Miner PB, Gaito JM. Bile flow in response to pharmacologic agents. Biochem Pharmacol. 1979;28:1063–1066
  25. Meyers RL, Book LS, O'Gorman MA, et al. High dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg. 2003;38:406–411
  26. Rhen T, Cidlowski JA. Mechanisms of disease: anti-inflammatory action of glucocorticoids—new mechanisms for old drugs. N Engl J Med. 2005;353:1711–1723
  27. Muraji T, Nio M, Ohhama Y, et al. Postoperative corticosteroid therapy for bile drainage in biliary atresia: a nationwide survey. J Pediatr Surg. 2004;39:1803–1805
  28. Davenport M, Stringer MD, Tizzard SA, et al. Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology. 2007;46:1821–1827
  29. Washburn LK, Nixon PA, O'Shea TM. Follow-up of a randomized, placebo-controlled trial of postnatal dexamethasone: blood pressure and anthropometric measurements at school age. Pediatrics. 2006;118:1592–1599
  30. Iuchi T, Akaike M, Mitsui T, et al. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res. 2003;92:81–87
  31. Windmeier C, Gressner AM. Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrosis. Gen Pharmacol. 1997;29:181–196
  32. Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev. 2006;58:488–520
  33. Conti M, Beavo JA. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Ann Rev Biochem. 2007;76:481–511
  34. Omori K, Kotera J. Overview of PDEs and their regulation. Circ Res. 2007;100:306–327
  35. Peterson T. Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor driven proliferation of fibroblast. Hepatology. 1993;17:486–493
  36. Preaux A, Mallat A, Rosenbaum J, et al. Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast cells. Hepatology. 1997;26:315–322
  37. Lee KS, Cottam HB, Houglum K, et al. Pentoxifylline blocks hepatic stellate cell activation independently of phosphodiesterase inhibitory activity. Am J Physiol Gastrointest Liver Physiol. 1997;273:1094–1100
  38. Anania F, Potter J, Rennie-Tankersley L, et al. Activation by acetaldehyde of the promoter of the mouse alpha-2 collagen gene when transfected into rat activated stellate cells. Arch Biochem Biophys. 1996;331:187–193
  39. Stark AR, Carol WA, Tyson JE, et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. N Engl J Med. 2001;344:95–101

PII: S0022-3468(09)00414-X

doi: 10.1016/j.jpedsurg.2009.05.020

Journal of Pediatric Surgery
Volume 44, Issue 11 , Pages 2071-2077 , November 2009

Article Tools

* Image Usage & Resolution